My Gene Counsel
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Solutions
    • Genetic Counselor Multiplier
    • Living Lab Reports
    • One-Stop Program
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
Tennis Star Chris Evert Teaches Us That Genetic Testing Is a Lifetime Match

Tennis Star Chris Evert Teaches Us That Genetic Testing Is a Lifetime Match

by Caitlin Kingsley | Jan 17, 2022 | News

This weekend, Chris Evert tweeted that she was diagnosed with early-stage (Stage 1C) ovarian cancer, which is associated with an outstanding survival rate. This news is especially good because most people diagnosed with ovarian cancer are diagnosed at stage III or IV,...
My Gene Counsel Quoted in Washington Post and Kaiser Health News

My Gene Counsel Quoted in Washington Post and Kaiser Health News

by Caitlin Kingsley | Feb 9, 2021 | News

As seen on The Washington Post and Kaiser Health News By Christina Bennett When her gynecologist recommended genetic testing, Mai Tran was reluctant. “I didn’t really want to do it,” recalled Tran, who had just turned 21 and was living in New...
Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

by Caitlin Kingsley | Feb 6, 2020 | News

Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...
With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

by Caitlin Kingsley | Jan 9, 2020 | News

Since its launch in 2013, ClinVar has not only amassed a wealth of genetic variant information, but the lab and clinical genetics community in the US are readily referencing it when they have questions about the clinical significance of variants. A few healthcare...
Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Personalized Medicine in 2019: Options Increasing But Are They Reaching Patients?

by Caitlin Kingsley | Jan 2, 2020 | News

In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
12Next >

Recent Posts

  • Genetic Testing Challenges in Oncology: Karyotype, Germline Clues in Somatic Diagnosis Lost in Translation
  • Genetic Testing Challenges in Oncology: Patient with Pending Bill has BRCA1 Result Withheld
  • Precision Oncology in 2022: New Drugs and Tests Amid Ongoing Access Barriers
  • NSGC 2022 Poster Presentation
  • The Genetics of Pancreatic Cancer

Archives

  • About Us
  • One-Stop Solution
  • Living Lab Reports®
  • Media
  • Genetic Journal Blog
  • Career Resources
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Contact Us
  • FAQs
  • Privacy Policy

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©